How CBD can help for Diabetic Retinopathy

Diabetic retinopathy is one of the main eye health complications that occur in patients diagnosed with diabetes. In this context, according to data from the World Health Organization (WHO), it is estimated that 1 in 3 diabetic patients will develop this complication at the ocular level, a figure that necessarily increases according to the natural aging of the retina in adult patients. higher.

With this in mind and with the support of the information compiled by the specialists of the International Diabetes Federation (IDF), in less than 30 years, the number of people between 20 and 79 years of age diagnosed with diabetes will oscillate between 642 million people worldwide.

Of which, undoubtedly, there is a very high number of people who live without knowing that they have diabetes. And, likewise, there’s a chance that just over 30 percent of that population will have (or develop) diabetic retinopathy.

Specifically 215 billion people expected by the year 2045.

According to the information deposited in an article published by the news chain of the specialized portal Nación Cannabis, a precise methodology could be established for the control of the antioxidant effect that would work as a mechanism of preventive medicine in vascular and retinal degeneration.

A preclinical study carried out in 2006 found that cannabidiol (CBD) may have a protective effect on the eyes in diabetics, given its powerful antioxidant effect that would serve as a preventive form of vascular and retinal degeneration. Likewise, the high concentration of powerful antioxidants with neuroprotective effects contained in the cannabis plant could be very useful in other processes associated with aging, beyond visual acuity problems.